Effect of dupilumab on asthma and aeroallergen sensitization in pediatric atopic dermatitis patients: Results of the BioDay registry.

Lisa P van der RijstKarin M de Winter-de GrootNicolaas P A ZuithoffMarjolein S de Bruin-WellerMarlies de Graaf

Published in: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology (2024)

One year of dupilumab treatment, primarily indicated for AD, resulted in a significant improvement in comorbid asthma and a profound decrease in aeroallergen-specific IgE levels in patients with asthma and/or AR.

Keyphrases

atopic dermatitis
chronic obstructive pulmonary disease
lung function
end stage renal disease
allergic rhinitis
chronic kidney disease
cystic fibrosis
intellectual disability
patient reported outcomes
autism spectrum disorder
young adults